AVEO Pharmaceuticals - Stock Price History | AVEO

Historical daily share price chart and data for AVEO Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for AVEO Pharmaceuticals as of May 29, 2020 is 8.16.
  • The all-time high AVEO Pharmaceuticals stock closing price was 207.70 on July 21, 2011.
  • The AVEO Pharmaceuticals 52-week high stock price is 11.20, which is 37.3% above the current share price.
  • The AVEO Pharmaceuticals 52-week low stock price is 2.23, which is 72.7% below the current share price.
  • The average AVEO Pharmaceuticals stock price for the last 52 weeks is 6.60.
AVEO Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 8.3998 18.3000 21.2000 5.1000 6.2430 -60.98%
2018 25.1285 27.4000 34.8000 14.9000 16.0000 -42.65%
2017 19.3154 6.0330 39.9000 5.7000 27.9000 416.67%
2016 8.9026 12.6000 12.6000 5.4000 5.4000 -57.14%
2015 13.8324 8.8000 24.9000 8.0000 12.6000 49.96%
2014 13.1489 18.0000 20.1000 6.5000 8.4020 -54.09%
2013 39.7181 80.7750 87.4000 16.1000 18.3000 -77.27%
2012 108.8962 138.3000 149.7000 59.7000 80.5000 -53.20%
2011 161.9282 148.7000 207.7000 130.6000 172.0000 17.65%
2010 102.7713 89.9000 174.1000 61.0500 146.2000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.131B $0.029B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $135.120B 14.88
Gilead Sciences (GILD) United States $97.628B 12.66
CSL (CSLLY) Australia $84.053B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.661B 51.33
Regeneron Pharmaceuticals (REGN) United States $67.420B 25.99
Illumina (ILMN) United States $53.368B 54.84
Biogen (BIIB) United States $50.113B 8.58
Seattle Genetics (SGEN) United States $27.213B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.477B 11.38
Moderna (MRNA) United States $22.830B 0.00
Incyte (INCY) United States $22.152B 0.00
Genmab (GMAB) Denmark $19.891B 16.38
Genmab (GNMSF) Denmark $19.309B 57.33
BioMarin Pharmaceutical (BMRN) United States $19.268B 174.67
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.532B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.144B 38.92
Exact Sciences (EXAS) United States $12.860B 0.00
BeiGene (BGNE) Cayman Islands $12.803B 0.00
Sarepta Therapeutics (SRPT) United States $11.875B 0.00
BioNTech SE (BNTX) Germany $11.207B 0.00
Bio-Techne Corp (TECH) United States $10.121B 66.87
QIAGEN (QGEN) Netherlands $9.973B 29.00
Horizon Therapeutics Public (HZNP) Ireland $9.678B 23.82
ARGENX SE-ADR (ARGX) Netherlands $9.384B 0.00
Guardant Health (GH) United States $8.549B 0.00
Immunomedics (IMMU) United States $7.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.743B 0.00
Exelixis (EXEL) United States $7.578B 26.57
Ascendis Pharma (ASND) Denmark $6.981B 0.00
Repligen (RGEN) United States $6.851B 120.16
Acceleron Pharma (XLRN) United States $5.320B 0.00
Adaptive Biotechnologies (ADPT) United States $4.911B 0.00
Reata Pharmaceuticals (RETA) United States $4.830B 0.00
MyoKardia (MYOK) United States $4.775B 0.00
Emergent Biosolutions (EBS) United States $4.377B 28.69
China Biologic Products (CBPO) China $4.360B 24.24
Mirati Therapeutics (MRTX) United States $4.329B 0.00
Zai Lab (ZLAB) China $4.323B 0.00
Global Blood Therapeutics (GBT) United States $4.261B 0.00
MorphoSys AG (MOR) Germany $4.259B 33.03
Ultragenyx Pharmaceutical (RARE) United States $4.084B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.941B 86.11
Momenta Pharmaceuticals (MNTA) United States $3.705B 0.00
Bluebird Bio (BLUE) United States $3.541B 0.00
Blueprint Medicines (BPMC) United States $3.530B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.272B 0.00
Amicus Therapeutics (FOLD) United States $3.214B 0.00
Arena Pharmaceuticals (ARNA) United States $3.009B 0.00
UniQure (QURE) Netherlands $2.976B 0.00
Denali Therapeutics (DNLI) United States $2.940B 0.00
NeoGenomics (NEO) United States $2.811B 205.31
Novavax (NVAX) United States $2.668B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Alkermes (ALKS) Ireland $2.597B 51.13
Alector (ALEC) United States $2.584B 0.00
Fate Therapeutics (FATE) United States $2.520B 0.00
Insmed (INSM) United States $2.454B 0.00
Viela Bio (VIE) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.380B 0.00
Inovio Pharmaceuticals (INO) United States $2.332B 0.00
Principia Biopharma (PRNB) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.885B 0.00
Epizyme (EPZM) United States $1.774B 0.00
Zymeworks (ZYME) Canada $1.736B 0.00
Adverum Biotechnologies (ADVM) United States $1.650B 0.00
Ligand Pharmaceuticals (LGND) United States $1.630B 63.48
Dicerna Pharmaceuticals (DRNA) United States $1.594B 0.00
Sangamo Therapeutics (SGMO) United States $1.576B 0.00
Twist Bioscience (TWST) United States $1.555B 0.00
Zealand Pharma (ZEAL) Denmark $1.514B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Akcea Therapeutics (AKCA) United States $1.506B 0.00
Mesoblast (MESO) Australia $1.490B 0.00
Editas Medicine (EDIT) United States $1.489B 0.00
Arcus Biosciences (RCUS) United States $1.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.440B 0.00
I-Mab (IMAB) China $1.423B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
REGENXBIO (RGNX) United States $1.403B 0.00
Intra-Cellular Therapies (ITCI) United States $1.388B 0.00
NGM Biopharmaceuticals (NGM) United States $1.344B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.322B 9.23
Beam Therapeutics (BEAM) United States $1.315B 0.00
Arvinas (ARVN) United States $1.303B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.083B 55.88
Nabriva Therapeutics AG (NBRV) Ireland $1.079B 0.00
Sorrento Therapeutics (SRNE) United States $1.059B 0.00
Compugen (CGEN) Israel $1.053B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.959B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Athenex (ATNX) United States $0.887B 0.00
NextCure (NXTC) United States $0.859B 0.00
Heska (HSKA) United States $0.826B 0.00
Cue Biopharma (CUE) United States $0.787B 0.00
Cellectis S.A (CLLS) France $0.784B 0.00
Alcobra (ARCT) United States $0.775B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.752B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Codexis (CDXS) United States $0.733B 0.00
Kadmon Holdings (KDMN) United States $0.711B 0.00
Retrophin (RTRX) United States $0.677B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
NantKwest (NK) United States $0.664B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Vericel (VCEL) United States $0.649B 119.83
Vanda Pharmaceuticals (VNDA) United States $0.639B 5.48
Morphic Holding (MORF) United States $0.636B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.634B 0.00
Bellus Health (BLU) Canada $0.632B 0.00
Agenus (AGEN) United States $0.624B 0.00
Stemline Therapeutics (STML) United States $0.624B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.585B 0.00
Frequency Therapeutics (FREQ) United States $0.576B 0.00
Athersys (ATHX) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.564B 0.00
MeiraGTx Holdings (MGTX) United States $0.554B 0.00
Scholar Rock Holding (SRRK) United States $0.550B 0.00
DBV Technologies S.A (DBVT) France $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.532B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 0.00
AnaptysBio (ANAB) United States $0.520B 0.00
VBI Vaccines (VBIV) United States $0.503B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.502B 0.00
UROGEN PHARMA (URGN) United States $0.490B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.479B 0.00
BioDelivery Sciences (BDSI) United States $0.478B 25.16
Anika Therapeutics (ANIK) United States $0.476B 15.31
Aquinox Pharmaceuticals (NLTX) United States $0.467B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
CytomX Therapeutics (CTMX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.402B 0.00
Albireo Pharma (ALBO) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.381B 327.00
ANI Pharmaceuticals (ANIP) United States $0.376B 7.45
Intrexon (PGEN) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.355B 0.00
Kamada (KMDA) Israel $0.349B 14.54
Avid Bioservices (CDMO) United States $0.330B 0.00
Menlo Therapeutics (MNLO) United States $0.326B 0.00
Geron (GERN) United States $0.323B 0.00
MannKind (MNKD) United States $0.322B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.316B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Verastem (VSTM) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
ADMA Biologics Inc (ADMA) United States $0.284B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.267B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Liquidia Technologies (LQDA) United States $0.262B 0.00
Starpharma Holdings (SPHRY) Australia $0.259B 0.00
Affimed (AFMD) Germany $0.251B 0.00
Pfenex (PFNX) United States $0.250B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Exicure (XCUR) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
ARAVIVE, INC (ARAV) United States $0.204B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
IVERIC Bio (ISEE) United States $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.200B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.194B 0.00
Cerecor (CERC) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
IBio (IBIO) United States $0.189B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
Aytu Bioscience (AYTU) United States $0.179B 0.00
Antibe Therapeutics (ATBPF) Canada $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Celyad SA (CYAD) Belgium $0.158B 0.00
TELA Bio (TELA) United States $0.157B 0.00
Arbutus Biopharma (ABUS) Canada $0.150B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Trevena (TRVN) United States $0.139B 0.00
Theratechnologies (THTX) Canada $0.139B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.132B 0.00
VolitionRX (VNRX) United States $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.98
CorMedix Inc (CRMD) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
Protalix BioTherapeutics (PLX) Israel $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.107B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.093B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Organovo Holdings (ONVO) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Happiness Biotech Group (HAPP) China $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Signal Genetics (MGEN) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
OvaScience (MLND) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Curis (CRIS) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.030B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00